Just Describe the Protein You Want. This AI Builds It, and It Works
A protein language model called Pinal designs working enzymes from plain-English prompts. What the Nature paper proves, and what it does not.
Editor's picks
See all
No Federal AI Law? How US States Are Quietly Writing the Rules for Health AI
The US still has no federal AI law. We map how state AI laws now govern health AI, from chatbot crisis rules to human review of insurance denials, and what federal preemption could change.
AI-Designed Longevity Drugs Are in Human Trials. Do Any of Them Work?
AI Is Reading Disease One Cell at a Time. Is the Hype Ahead of the Data?
Can AI Read DNA Without Being Taught the Genetic Code?
If Your DNA Trains an AI That Finds a Blockbuster Drug, Who Gets Paid?
AI
See all
Virology
See all
Recent posts
See all
AI Is Rewiring Microbes to Brew Our Medicines. Is It Working?
Synthetic biology is handing the design of medicine-making microbes to machine learning. We look at what AI-guided strain engineering has actually delivered, where it still stalls, and what the evidence supports.
Can an AI Chatbot Replace Your Therapist? What the 2026 Trials Really Show
AI therapy is being tested in real clinical trials. We read the 2025 and 2026 evidence on chatbot therapy for depression and anxiety, the safety gaps, and what regulators say.
100 Days to a Vaccine: Can AI Really Deliver the Pandemic Moonshot?
The 100 Days Mission wants a vaccine authorised within 100 days of spotting a new pandemic threat. We look at what AI has actually delivered, using the 2026 Ebola outbreak as a live test.
Convergent Evolution Keeps Repeating Itself. Can AI Explain Why?
Convergent evolution gave bats and dolphins sonar and turned lobster relatives into crabs. Machine learning is now finding the genes behind these repeats. Here is what the evidence shows.
The EU AI Act's Next Deadline Is Weeks Away. Should AI Drug Designers Worry?
The EU AI Act's next deadline lands on 2 December 2026. We explain what it means for AI in drug discovery, which rules the Digital Omnibus delayed, and where the real compliance work for AI-designed drugs sits.
Rapamycin, Metformin or AI? The 2026 Evidence on Longevity Drugs
Rapamycin longevity data, metformin's mixed record and AI-designed drugs compared. What the human trials, mouse studies and ageing clocks actually show in 2026.
AI in Healthcare
See allAI Can Call Drug Resistance in Hours. Should Labs Trust It Yet?
AI diagnostics can now predict antibiotic and antiviral resistance from a pathogen genome with striking accuracy. We examine the 2026 evidence, and why Europe's own susceptibility testing committee says it is not ready for the clinic.
